Search

Alan D. Diamond

Examiner (ID: 4240, Phone: (571)272-1338 , Office: P/3991 )

Most Active Art Unit
1753
Art Unit(s)
3991, 1736, 1751, 1111, 1753, 1629
Total Applications
2040
Issued Applications
1465
Pending Applications
301
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18476580 [patent_doc_number] => RE049569 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-04 [patent_title] => Alkylamine derivative [patent_app_type] => reissue [patent_app_number] => 17/220471 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 22513 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220471 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/220471
Alkylamine derivative Mar 31, 2021 Issued
17/194645 Process For Producing Acesulfame Potassium Mar 7, 2021 Pending
17/193965 COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION Mar 4, 2021 Abandoned
Array ( [id] => 18699387 [patent_doc_number] => RE049700 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-17 [patent_title] => Substituted nitrogen containing compounds [patent_app_type] => reissue [patent_app_number] => 17/183286 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 101402 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183286 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183286
Substituted nitrogen containing compounds Feb 22, 2021 Issued
Array ( [id] => 18799390 [patent_doc_number] => RE049742 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-12-05 [patent_title] => Drug delivery system for administration of poorly water soluble pharmaceutically active substances [patent_app_type] => reissue [patent_app_number] => 17/177550 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 12162 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/177550
Drug delivery system for administration of poorly water soluble pharmaceutically active substances Feb 16, 2021 Issued
17/177544 DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES Feb 16, 2021 Abandoned
17/175078 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION Feb 11, 2021 Abandoned
Array ( [id] => 18683223 [patent_doc_number] => RE049687 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-10 [patent_title] => Thienopyrimidine and thienopyridine compounds and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 17/165794 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 64794 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165794 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/165794
Thienopyrimidine and thienopyridine compounds and methods of use thereof Feb 1, 2021 Issued
17/152120 INHIBITION OF MK2 IN THE TREATMENT OF CANCER Jan 18, 2021 Abandoned
Array ( [id] => 18502988 [patent_doc_number] => RE049582 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-18 [patent_title] => Therapeutic compounds and compositions [patent_app_type] => reissue [patent_app_number] => 17/131562 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 60615 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131562 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131562
Therapeutic compounds and compositions Dec 21, 2020 Issued
90/014599 PROCESS FOR PREPARING CYCLOPHOSPHAMIDE, INTERMEDIATES, AND MONOHYDRATE THEREOF Dec 16, 2020 Issued
Array ( [id] => 18699384 [patent_doc_number] => RE049697 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-17 [patent_title] => Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations [patent_app_type] => reissue [patent_app_number] => 17/104028 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 19054 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104028
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Nov 24, 2020 Issued
Array ( [id] => 19011027 [patent_doc_number] => RE049860 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-03-05 [patent_title] => Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient [patent_app_type] => reissue [patent_app_number] => 17/087659 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13964 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/087659
Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient Nov 2, 2020 Issued
Array ( [id] => 18683222 [patent_doc_number] => RE049686 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-10 [patent_title] => Nitrogen-containing heterocyclic compound and use of same [patent_app_type] => reissue [patent_app_number] => 17/076227 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70750 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076227 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/076227
Nitrogen-containing heterocyclic compound and use of same Oct 20, 2020 Issued
Array ( [id] => 18618463 [patent_doc_number] => RE049647 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-09-12 [patent_title] => Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione [patent_app_type] => reissue [patent_app_number] => 17/030272 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24797 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/030272
Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Sep 22, 2020 Issued
Array ( [id] => 18426994 [patent_doc_number] => RE049551 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-06-13 [patent_title] => Heterogeneous catalyst for transesterification and method of preparing same [patent_app_type] => reissue [patent_app_number] => 17/019691 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3322 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/019691
Heterogeneous catalyst for transesterification and method of preparing same Sep 13, 2020 Issued
Array ( [id] => 18558074 [patent_doc_number] => RE049610 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-08-15 [patent_title] => Heterogeneous catalyst for transesterification and method of preparing same [patent_app_type] => reissue [patent_app_number] => 17/019903 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3334 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019903 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/019903
Heterogeneous catalyst for transesterification and method of preparing same Sep 13, 2020 Issued
Array ( [id] => 18100564 [patent_doc_number] => RE049352 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-01-03 [patent_title] => Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists [patent_app_type] => reissue [patent_app_number] => 17/011592 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66591 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/011592
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Sep 2, 2020 Issued
Array ( [id] => 18443045 [patent_doc_number] => RE049555 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-06-20 [patent_title] => Process for producing a stable low concentration, injectable solution of noradrenaline [patent_app_type] => reissue [patent_app_number] => 17/006841 [patent_app_country] => US [patent_app_date] => 2020-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3618 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006841 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/006841
Process for producing a stable low concentration, injectable solution of noradrenaline Aug 29, 2020 Issued
90/014565 SOLVENT SYSTEMS FOR DICYANDIAMIDE AND/OR ALKYL THIOPHOSPHORIC TRIAMIDE AND USE IN AGRICULTURAL APPLICATIONS Aug 25, 2020 Issued
Menu